HMG CoA Reductase Inhibitors (Statins) for Dialysis Patients

doi 10.1002/14651858.cd004289.pub4
Full Text
Abstract

Available in full text

Date
Authors
Publisher

John Wiley & Sons, Ltd

Related search

HMG CoA Reductase Inhibitors (Statins) for People With Chronic Kidney Disease Not Requiring Dialysis

Cochrane Database of Systematic Reviews
2014English

Inflammation, Immunity, and HMG-CoA Reductase Inhibitors: Statins as Antiinflammatory Agents?

Circulation
Cardiovascular MedicinePhysiologyCardiology
2004English

Cholesterol, C-Reactive Protein, and Periodontitis: HMG-CoA-Reductase Inhibitors (Statins) as Effect Modifiers

ISRN Dentistry
2011English

HMG-CoA Reductase Inhibitors (Statins) Might Cause High Elevations of Creatine Phosphokinase (CK) in Patients With Unnoticed Hypothyroidism

Endocrine Journal
EndocrinologyMetabolismDiabetes
2006English

Pleiotropic Effects of the HMG-CoA Reductase Inhibitors

International Journal of General Medicine
Medicine
2011English

HMG-CoA Reductase Inhibitors (Statins) Increase Endothelial Progenitor Cells via the PI 3-Kinase/Akt Pathway

Journal of Clinical Investigation
Medicine
2001English

HMG-CoA Reductase Inhibitors and the Risk of Hip Fractures in Elderly Patients

JAMA - Journal of the American Medical Association
Medicine
2000English

Role of HMG-CoA Reductase Inhibitors With Curative Radiotherapy in Men With Prostate Cancer

Research and Reports in Urology
Urology
2011English

Exploration of Virtual Candidates for Human HMG-CoA Reductase Inhibitors Using Pharmacophore Modeling and Molecular Dynamics Simulations

PLoS ONE
Multidisciplinary
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy